Marker Therapeutics, Inc. (MRKR)
Nasdaq: MRKR · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 1999
Who owns Marker Therapeutics, Inc.
As filed with the SECHolders of 5% or more
3
Blue Owl Capital Holdings LP holds 9.99% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G/A filed May 15, 2025 says.
Directors and officers
5
report now, of 26 people on the record since 2007. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Blue Owl Capital Holdings LP
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, par value $0.001 per share · 5.18% in Feb 14, 2025
New Enterprise Associates 16, L.P.
SCHEDULE 13D/A · filed Nov 17, 2025 · Common Stock, par value $0.001 per share · 12.6% in Aug 18, 2025
Alyeska Investment Group, L.P.
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.001 per share · 9.99% in Feb 14, 2025
John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017
SCHEDULE 13D/A · filed Aug 20, 2025 · Common Stock, Par Value $0.001 · reported falling below 5%, from 5.1% in Aug 19, 2025
What MRKR reports owning in othersstakes of 5% or more, and other ties
Marker Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2024 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.